Amgen's most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $105.00 short put and a strike $97.50 long put offers a potential 5.34% return on risk over the next 29 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $105.00 by expiration. The full premium credit of $0.38 would be kept by the premium seller. The risk of $7.12 would be incurred if the stock dropped below the $97.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.
The RSI indicator is at 55.92 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Stocks at 1-year highs: Amgen, Starbucks & more
Fri, 18 Oct 2013 16:48:00 GMT
CNBC – There are over 100 S&P 500 stocks soaring to new 52-week highs. The FMHR traders take their positions.
Bubble-icious Biotech
Fri, 18 Oct 2013 11:32:00 GMT
Forbes – Actual bubble, not to be confused with the metaphorical bubble discussed at left. (Photo credit: Wikipedia) For me, one glance was all it took. Looking at my colleague's computer from across the room, I could see that this pre-IPO company's lead oncology asset — presumably the driving force behind this white-hot offering […]
Earnings Preview: Amgen to report 3Q results
Fri, 18 Oct 2013 10:34:08 GMT
Earnings Preview: Amgen to report 3Q results
Fri, 18 Oct 2013 10:34:08 GMT
AP – Biotech drugmaker Amgen Inc. will focus on the integration and strategy behind its acquisition of Onyx Pharmaceuticals, which makes two cancer drugs and has others in testing, when it reports third-quarter …
Amgen Announces Webcast of 2013 Third Quarter Financial Results
Thu, 17 Oct 2013 20:25:00 GMT
PR Newswire – THOUSAND OAKS, Calif. , Oct. 17, 2013 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Tuesday, Oct. 22, 2013, after the close of the U.S. …
Related Posts
Also on Market Tamer…
Follow Us on Facebook